Insider · CIK 0001727358
TacticGem LLC
Files at MNPR (Monopar Therapeutics). First filing -, latest -.
TacticGem LLC files SEC Form 4 as 10% owner at MNPR (Monopar Therapeutics). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; TacticGem LLC has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 9, 2024 | MNPR Monopar Therapeutics | JOther Common Stock | -1,433,334 | $0.00 | $0 | 0 | Dec 17, 2024 |
Questions about TacticGem LLC
Answered from the filings on this page, as of the latest one.
Is TacticGem LLC buying or selling?
TacticGem LLC has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did TacticGem LLC's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and TacticGem LLC has 0.
Where does TacticGem LLC file Form 4?
TacticGem LLC has filed Form 4 at MNPR (Monopar Therapeutics). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.